Clinical Trial Update: Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing azacitidine (Vidaza) versus fludarabine and cytarabine (Fluga scheme) in elderly patients with newly diagnosed acute myeloid leukemia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Fluga scheme regimen (Fludarabine and Cytarabine) (fludarabine and cytarabine)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED